Trial intelligence / Profile preview

Metabolic syndrome and quality of life in Addison's disease during glucocorticoid replacement therapy

NL-OMON32767Withdrawn

Sponsor
University Medical Center Utrecht
Start
Feb 2010
Countries
1
01

Overview

Open-label, single-arm trial in Addison's disease, sponsored by University Medical Center Utrecht. Primary endpoints: Presence of metabolic syndrome and Quality of life score. Planned start Feb 2010; status: withdrawn.

02

Conditions

Addison's disease

Beyond the preview

Go deeper on NL-OMON32767.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON32767.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call